
Growth investor backing healthier-living food and drink brands, with advisors who are also investors

Boutique financial firm investing in and advising life sciences tools, diagnostics and biopharma services companies

BroadOak Capital Partners is a boutique financial institution that specialises in life sciences. Since 2006 it has invested directly through BroadOak Asset Management and offered investment banking through BroadOak Partners.
Companies making research instruments and consumables, diagnostic tests and instruments, and research and manufacturing services for biopharma. It reports investments in over 50 companies and advice on over 50 mergers and acquisitions. Named deals include Sanguine Biosciences, CDI Laboratories and PBS Biotech.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
As of 2026-10-08. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about BroadOak Capital Partners.
Similar listings buyers compare against this one.

Growth investor backing healthier-living food and drink brands, with advisors who are also investors
Bank offering banking, cards and financial advice to founders, executives and investors in the innovation economy

Impact-focused venture firm investing in education and workforce technology companies that have proven solutions

Deep tech venture fund backing patent-based science startups in the US Southwest and Northern Europe

Capital and advisory firm for blockchain projects, part of Faculty Group

Austin venture capital firm backing early-stage applied AI companies across North America
Everything here links back to the same verified catalogue. Pick your next stop.